市场调查报告书
商品编码
1374217
神经监测设备全球市场规模、份额和行业趋势分析报告:2023-2030 年按技术、产品和地区分類的展望和预测Global Nerve Monitoring Devices Market Size, Share & Industry Trends Analysis Report By Technology, By Product (Monitors, Electrodes, and Ancillary Products), By Regional Outlook and Forecast, 2023 - 2030 |
神经监测设备市场规模预计到 2030 年将达到 18 亿美元,预测期内年复合成长率年增长率为 5.2%。
根据 KBV Cardinal 矩阵中发布的分析,美敦力公司 (Medtronic PLC) 是市场领导者。 工业、Brainlab AG 和 Natus Medical Inc. 等公司是市场上的主要创新者。 2023 年 1 月,Natus Medical Incorporated 完成了对神经生理学领域全球领导者 Micromed Holding SAS 的收购。透过此次收购,神经科学用户现在可以透过整合资源获得全面的产品、全球服务和支援。
市场成长要素
由于外科手术的增加导致产品需求增加
许多外科手术都有固有的风险,包括神经损伤的可能性。神经监测设备可帮助外科医生和医疗保健专业人员即时识别和监测神经功能,降低手术期间无意损伤神经的风险。这种风险降低对于复杂且敏感的神经外科手术尤其重要。外科技术的进步扩大了外科手术的范围,包括微创手术和机器人辅助手术。这些先进的手术通常需要精确的神经系统监测,以确保最佳的结果和安全。耳鼻喉科手术的增加增加了对神经监测设备的需求。随着手术技术的发展和手术需求的增加,提高病人安全和手术效果的需求变得迫切,预计市场将继续发展。
神经监测设备的技术进步
技术进步正在显着推动市场成长。这些进步促进了更复杂、更准确、更易于使用的神经监测设备的发展,这些设备在各种手术和医疗情况中变得越来越有价值。现代神经监测设备为外科医生和医疗团队提供即时监测和即时回馈。这些即时资讯可以在手术过程中及时进行调整,并降低神经损伤的风险。神经监测设备越来越多地与手术导航系统整合,从而可以精确绘製和追踪神经途径。外科医生可以使用这些系统更准确地规划和执行手术。先进的软体功能改进了资料分析和视觉化。这些技术进步正在扩大可以进行研究监测的手术范围,并提高神经监测设备在医疗机构中的整体普及。
市场抑制因素
需要大量前期投资
神经监测设备属于资本集中设备,需要医疗机构进行大量的前期投资。这项费用可能会使医院的资源紧张,尤其是预算有限的小型或非营利组织。除了最初的购买成本之外,还存在维护和操作神经监测设备的持续成本。这包括定期维护、校准以及购买一次性电极和配件的成本。高成本可能导致全球在获得先进医疗技术方面存在差异。在某些地区,由于成本相关要素,神经监测设备的使用可能受到限制。这些要素阻碍了市场的成长。
产品展望
依产品划分,市场分为监视器、电极和辅助产品。 2022年,显示器部门市场以最大的收益占有率主导市场。这是由于外科手术、神经系统疾病的增加和技术的进步。主监测单元或装置接收来自电极的讯号并处理资料。通常显示有关神经功能的即时资讯。该设备还可以包括用于资料分析和视觉化的软体。这使得医疗保健专业人员能够在手术和医疗过程中追踪神经活动。预计未来年度对一次性海绵盘、一次性过滤器、酒精棉籤、抛光凝胶和电极洗液的需求将会增加。利用率的提高和重复购买预计将推动该领域的成长。
技术展望
根据技术,市场分为脑电图(EEG)、诱发电位、肌电图(EMG)和皮质电图(ECoG)。 2022 年,肌电图 (EMG) 领域在神经监测设备市场中占据了显着的收益占有率。肌电图是医疗保健专业人员诊断和监测影响神经肌肉系统状况的宝贵工具。肌电图测试的结果可以指南治疗决策、復健计画和神经肌肉疾病的管理。肌电图测试通常具有良好的耐受性,插入电极针期间的任何不适或轻微疼痛通常都是暂时的。肌电图测试通常由神经科、临床神经生理学家或经过专门培训的实验室技术人员进行。
区域展望
从区域来看,我们对北美、欧洲、亚太地区和拉丁美洲地区的市场进行了分析。 2022年,北美地区将占据市场最大的收益占有率。原因是复杂的医疗保健系统以及在创伤病例中越来越多地使用神经监测。此外,可支配所得的增加和有利的报销政策有利于预防和早期诊断,增加了对神经监测设备的需求。心血管疾病是美国的首要死因。由于心臟疾病的高患病,进行了大量的心臟外科手术,这可能导致神经损伤。
The Global Nerve Monitoring Devices Market size is expected to reach $1.8 billion by 2030, rising at a market growth of 5.2% CAGR during the forecast period.
Somatosensory Evoked Potentials (SSEPs) are a type of neurophysiological test used in clinical medicine to assess the function of the somatosensory pathways in the nervous system. SSEP testing involves measuring the electrical signals generated in response to sensory stimuli applied to specific peripheral nerves. Therefore, Somatosensory Evoked Potentials (SSEPs) segment generated $63.4 million revenue in the market in 2022. These tests provide valuable information about the integrity and function of sensory pathways, helping diagnose and monitor various neurological conditions. SSEP testing involves two primary steps: stimulation and recording. During stimulation, a controlled electrical stimulus or mechanical vibration is applied to a specific peripheral nerve, typically at various points along the limb. The stimulus travels along the sensory pathway towards the central nervous system.
The major strategies followed by the market participants are Mergers & Acquisition as the key developmental strategy to keep pace with the changing demands of end users. For instance, In September, 2022, Brainlab AG took over Dr. Langer Medical GmbH. Through this acquisition, Brainlab integrated Dr. Langer Medical GmbH's neuromonitoring services and solutions to amplify neuronavigation through the integration of critical data components. Additionally, In October, 2020, Medtronic PLC announced the acquisition of Avenu Medical, Inc. Through this acquisition, Medtronic has supported the vascular access care continuum and provided endovascular therapies to patients suffering from ESRD across the world.
Based on the Analysis presented in the KBV Cardinal matrix; Medtronic PLC is the forerunner in the Market. Companies such as Nihon Kohden Corporation, Brainlab AG, Natus Medical Inc. are some of the key innovators in the Market. In January, 2023, Natus Medical Incorporated completed the acquisition of Micromed Holding SAS, a global leader in neurophysiology. Through this acquisition, neuroscience users are able to access comprehensive products, global service and support through the combined resources.
Market Growth Factors
Rising demand for product owing to increasing surgical procedures
Many surgical procedures carry inherent risks, including the potential for nerve damage. Nerve monitoring devices help surgeons and healthcare professionals identify and monitor nerve function in real-time, reducing the risk of unintentional nerve injury during surgery. This risk mitigation is especially crucial in complex and delicate nervous system surgeries. Advances in surgical techniques have expanded the scope of surgical procedures, including minimally intrusive and robotic-assisted surgeries. These advanced procedures often require precise nerve monitoring to ensure optimal outcomes and safety. The increasing number of ENT surgeries contributes to the demand for nerve monitoring devices. As surgical techniques evolve and the demand for surgical procedures grows, the market is expected to develop continually, driven by the imperative to enhance patient safety and surgical outcomes.
Technological advancements in nerve monitoring devices
Technological advancements have significantly driven growth in the market. These advancements have led to the development of more sophisticated, accurate, and user-friendly nerve monitoring devices, making them increasingly valuable in various surgical and medical contexts. Modern nerve monitoring devices offer surgeons and medical teams real-time monitoring and immediate feedback. This real-time information allows for timely adjustments during surgery, reducing the risk of nerve damage. Nerve monitoring devices are increasingly integrated with surgical navigation systems, allowing for precise mapping, and tracking of nerve pathways. Surgeons can use these systems to plan and execute procedures more accurately. Advanced software capabilities have improved data analysis and visualization. These technological advancements have extended the range of surgeries where nerve monitoring is feasible and increased the overall adoption of nerve monitoring devices in healthcare settings.
Market Restraining Factors
Requirement of substantial upfront investments
Nerve monitoring devices can be capital-intensive, requiring a substantial upfront investment by healthcare facilities. This expenditure may strain the financial resources of hospitals, particularly smaller or non-profit institutions with limited budgets. Beyond the initial purchase cost, ongoing expenses are associated with maintaining and operating nerve monitoring devices. This includes the cost of regular maintenance, calibration, and the purchase of disposable electrodes and accessories. High costs can contribute to global disparities in access to advanced healthcare technologies. Some regions may have limited access to nerve monitoring devices due to cost-related factors. Due to such factors, market growth will be hampered.
Product Outlook
On the basis of product, the market is segmented into monitors, electrodes, and ancillary products. In 2022, the monitors segment dominated the market with the maximum revenue share. Due to the increasing number of surgical processes, neurological disorders, and technological advancements. The main monitoring unit or device receives signals from the electrodes and processes the data. It typically displays real-time information about nerve function. This equipment may have built-in software for data analysis and visualization. It allows healthcare professionals to track nerve activity during surgery or medical procedures. In the coming years, disposable sponge disks, disposable filters, alcohol swabs, abrasive gel, and electrode lotions are expected to increase in demand. Increased utilization and repeat purchases will likely drive segment growth.
Technology Outlook
Based on technology, the market is fragmented into electroencephalogram (EEG), evoked potential, electromyography (EMG), and electrocorticography (ECoG). The electromyography (EMG) segment recorded a remarkable revenue share in the nerve monitoring device market in 2022. EMG is a valuable tool for healthcare professionals to diagnose and monitor conditions affecting the neuromuscular system. The results of EMG testing help guide treatment decisions, rehabilitation programs, and the management of neuromuscular disorders. The procedure is generally well-tolerated, and discomfort or mild pain during needle electrode insertion is usually temporary. EMG testing is typically performed by neurologists, clinical neurophysiologists, or specially trained technologists.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region witnessed the largest revenue share in the market. Due to its sophisticated healthcare system and the rising usage of nerve monitoring in trauma cases. Moreover, rising disposable income and favorable reimbursement policies facilitate preventive & early diagnosis, thereby increasing the demand for nerve monitoring devices. Cardiovascular disease is the foremost cause of death in the US. As a result of the high prevalence of cardiac disease, numerous cardiological surgical procedures are conducted, which can potentially lead to nerve damage.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, NuVasive, Inc., Natus Medical Inc., Neuspera Medical, Inc., Brainlab AG, Checkpoint Surgical, Inc., Cadwell Industries, Inc., Compumedics Limited, Magstim EGI (Magstim, Inc.), and Nihon Kohden Corporation.
Recent Strategies Deployed in Nerve Monitoring Devices Market
Partnerships, Collaborations, and Agreements:
Aug-2023: Brainlab AG expanded its partnership with ZimVie Inc., a global life sciences leader in the dental and spine markets. Through this extended partnership, ZimVie's Vital and Virage spinal fixation systems were amalgamated with the spine and trauma technologies of Brainlab. Additionally, the companies helped surgeons to place pedicle screws, minimize exposure of radiation and plan and execute spinal procedures.
Product Launches and Product Expansions:
Aug-2023: Cadwell Industries, Inc. released the Sierra NMUS1 neuromuscular ultrasound device which helps in providing electrodiagnostic medicine. The Sierra NMUS1 provides high-resolution neuromuscular and musculoskeletal ultrasound, needle guidance capabilities along with combined controls and an organized interface in the Sierra 4 software.
Apr-2023: Cadwell Industries, Inc. unveiled the Arc Voyager which is a solution for remotely monitoring wireless In-Home EEG. The Arc Voyager along with the Arc Apollo+ EEG can be used by the physicians for regulating the data of the patients using in-home ambulatory tests.
Oct-2022: Nihon Kohden Corporation introduced the Smart Cable NMT Pod and disposable electrode which assists clinicians in the regulation of neuromuscular blockade. The Smart Cable NMT Pod and disposable electrode monitors the depth of paralysis of the patient during surgery after the administration of the neuromuscular blockade agent (NMBA).
Sep-2022: Checkpoint Surgical, Inc. added the CHECKPOINT GEMINI to its intraoperative nerve stimulators. Checkpoint Gemini has the features of a bipolar probe design thus helping to focus the released energy into a limited area. Additionally, the Checkpoint Gemini provides precise stimulation and helps the surgeons with optimal solutions relating to clinical nerve procedures.
Jul-2022: Checkpoint Surgical, Inc. introduced the Checkpoint Edge Nerve Cutting Kit into its portfolio of intraoperative nerve care. The Checkpoint Edge added new features into the company's stimulator and implant products. Additionally, the Checkpoint Edge assisted the surgeon in protecting and preserving nerve tissue at the time of nerve transection.
Acquisition and Mergers:
Jan-2023: Natus Medical Incorporated completed the acquisition of Micromed Holding SAS, a global leader in neurophysiology. Through this acquisition, the neuroscience users able to access comprehensive products, global service and support through the combined resources.
Sep-2022: Brainlab AG took over Dr. Langer Medical GmbH, a manufacturer of medical equipment and medical devices. Through this acquisition, Brainlab integrated Dr. Langer Medical GmbH's neuromonitoring services and solutions to amplify neuronavigation through the integration of critical data components.
May-2022: Brainlab AG completed the acquisition of medPhoton GmbH, engaged in manufacturing robotic imaging solutions. Through this acquisition, Loop-X was upgraded and the roadmap for intraoperative imaging was paved.
Feb-2021: NuVasive, Inc. acquired Simplify Medical Inc., engaged in designing and manufacturing cervical artificial discs. Through this acquisition, the clinically effective cTDR technology was added to NuVasive's portfolio. Additionally, the acquisition upgraded NuVasive's growth strategy of expansion of its portfolio through industry-leading innovation.
Oct-2020: Medtronic PLC announced the acquisition of Avenu Medical, Inc., a medical device company. Through this acquisition, Medtronic has supported the vascular access care continuum and provided endovascular therapies to patients suffering from ESRD across the world.
Feb-2020: Medtronic PLC took over Digital Surgery, a privately held pioneer in surgical artificial intelligence (AI), data and analytics. Through this acquisition, Medtronic upgraded its portfolio and the robotic-assisted surgery platform. Additionally, the acquisition helped combining robotic platforms and instrumentations digitally thus expanding the reach of patients.
Market Segments covered in the Report:
By Technology
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research